Physicians' Academy for Cardiovascular Education

What have we learned from previous CETP inhibitor outcome trials?

Listen to the podcast
10' education - Sep. 15, 2022 - Prof. Stephen Nicholls, MD - Melbourne, Australia

Video navigation menu

  • Previous CV outcome trials with CETP inhibitors 00:24
  • Clinical trial program for obicetrapib 06:56

Transcript

Show transcript

Educational information

This presentation by Prof. Nicholls is the second part of an educational series about CETP inhibitors.

Faculty

Prof. Stephen Nicholls is a cardiologist, and leads the Victorian Heart Hospital (VHH) in Melbourne, Australia, which is due to open in 2022.

Disclosures

This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

Funding

Funding for this educational program was provided by an unrestricted educational grant received from New Amsterdam Pharma.

Watch the other videos in this series View the slides of this presentation

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: